周文华, 尹晶晶, 高洁, 刘欢, 王若琪, 李建国. 体内铀毒性及其新型促排剂研究进展[J]. 中国辐射卫生, 2022, 31(3): 379-385.
ZHOU Wenhua, YING Jinjin, GAO Jie, LIU Huan, WANG Ruoqi, LI Jianguo. Research advances in toxicity of uranium in vivo and its new chelators. Chinese Journal of Radiological Health, 2022, 31(3): 379-385.
[1] Bjørklund G, Semenova Y, Pivina L, et al. Uranium in drinking water: a public health threat[J]. Arch Toxicol, 2020, 94(5): 1551-1560. DOI: 10.1007/s00204-020-02676-8 [2] Yue YC, Li MH, Wang HB, et al. The toxicological mechanisms and detoxification of depleted uranium exposure[J]. Environ Health Prev Med, 2018, 23(1): 18. DOI: 10.1186/s12199-018-0706-3 [3] Ma MH, Wang RX, Xu LN, et al. Emerging health risks and underlying toxicological mechanisms of uranium contamination: lessons from the past two decades[J]. Environ Int, 2020, 145: 106107. DOI: 10.1016/j.envint.2020.106107 [4] 覃志英, 刘建华, 唐孟俭, 等. 某退役铀矿山周围居民淋巴细胞微核率分析[J]. 中国辐射卫生,2019,28(4):376-378,381. DOI: 10.13491/j.issn.1004-714x.2019.04.007 Qin ZY, Liu JH, Tang MJ, et al. Analysis of the micronucleus rate of peripheral blood lymphocytes of healthy residents around a retired uranium mine[J]. Chin J Radiol Health, 2019, 28(4): 376-378,381. DOI: 10.13491/j.issn.1004-714x.2019.04.007 [5] Kolhe N, Zinjarde S, Acharya C. Responses exhibited by various microbial groups relevant to uranium exposure[J]. Biotechnol Adv, 2018, 36(7): 1828-1846. DOI: 10.1016/j.biotechadv.2018.07.002 [6] Carugo O. Structural features of uranium-protein complexes[J]. J Inorg Biochem, 2018, 189: 1-6. DOI: 10.1016/j.jinorgbio.2018.08.014 [7] Vicente-Vicente L, Quiros Y, Pérez-Barriocanal F, et al. Nephrotoxicity of uranium: pathophysiological, diagnostic and therapeutic perspectives[J]. Toxicol Sci, 2010, 118(2): 324-347. DOI: 10.1093/toxsci/kfq178 [8] Ran YH, Wang S, Zhao YZ, et al. A review of biological effects and treatments of inhaled depleted uranium aerosol[J]. J Environ Radioact, 2020, 222: 106357. DOI: 10.1016/j.jenvrad.2020.106357 [9] Kim YS, Park HS, Kim JY, et al. Health risk assessment for uranium in Korean groundwater[J]. J Environ Radioact, 2004, 77(1): 77-85. DOI: 10.1016/j.jenvrad.2004.03.001 [10] Kitahara K, Numako C, Terada Y, et al. Uranium XAFS analysis of kidney from rats exposed to uranium[J]. J Synchrotron Rad, 2017, 24(2): 456-462. DOI: 10.1107/S1600577517001850 [11] 张旭霞, 暴一众, 王梦梦, 等. 螯合剂与金属硫蛋白对铀的竞争结合作用[J]. 中国辐射卫生,2019,28(1):12-16. DOI: 10.13491/j.issn.1004-714x.2019.01.004 Zhang XX, Bao YZ, Wang MM, et al. Competitive combination with uranium (VI) between chelating agent and metallothionein[J]. Chin J Radiol Health, 2019, 28(1): 12-16. DOI: 10.13491/j.issn.1004-714x.2019.01.004 [12] Gao N, Huang ZH, Liu HQ, et al. Advances on the toxicity of uranium to different organisms[J]. Chemosphere, 2019, 237: 124548. DOI: 10.1016/j.chemosphere.2019.124548 [13] Rump A, Eder S, Lamkowski A, et al. A quantitative comparison of the chemo- and radiotoxicity of uranium at different enrichment grades[J]. Toxicol Lett, 2019, 313: 159-168. DOI: 10.1016/j.toxlet.2019.07.004 [14] Huynh TNS, Vidaud C, Hagège A. Investigation of uranium interactions with calcium phosphate-binding proteins using ICP/MS and CE-ICP/MS[J]. Metallomics, 2016, 8(11): 1185-1192. DOI: 10.1039/c6mt00147e [15] Bourgeois D, Burt-Pichat B, Le Goff X, et al. Micro-distribution of uranium in bone after contamination: new insight into its mechanism of accumulation into bone tissue[J]. Anal Bioanal Chem, 2015, 407(22): 6619-6625. DOI: 10.1007/s00216-015-8835-7 [16] Pierrefite-Carle V, Santucci-Darmanin S, Breuil V, et al. Effect of natural uranium on the UMR-106 osteoblastic cell line: impairment of the autophagic process as an underlying mechanism of uranium toxicity[J]. Arch Toxicol, 2017, 91(4): 1903-1914. DOI: 10.1007/s00204-016-1833-5 [17] Gritsaenko T, Pierrefite-Carle V, Lorivel T, et al. Natural uranium impairs the differentiation and the resorbing function of osteoclasts[J]. Biochim Biophys Acta Gen Subj, 2017, 1861(4): 715-726. DOI: 10.1016/j.bbagen.2017.01.008 [18] Hurault L, Creff G, Hagège A, et al. Uranium effect on osteocytic cells in vitro[J]. Toxicol Sci, 2019, 170(1): 199-209. DOI: 10.1093/toxsci/kfz087 [19] Wade-Gueye NM, Delissen O, Gourmelon P, et al. Chronic exposure to natural uranium via drinking water affects bone in growing rats[J]. Biochim Biophys Acta Gen Subj, 2012, 1820(7): 1121-1127. DOI: 10.1016/j.bbagen.2012.04.019 [20] Yi J, Yuan Y, Zheng JF, et al. Hydrogen sulfide alleviates uranium-induced rat hepatocyte cytotoxicity via inhibiting Nox4/ROS/p38 MAPK pathway[J]. J Biochem Mol Toxicol, 2019, 33(3): e22255. DOI: 10.1002/jbt.22255 [21] Yuan Y, Zheng JF, Zhao TT, et al. Hydrogen sulfide alleviates uranium-induced acute hepatotoxicity in rats: role of antioxidant and antiapoptotic signaling[J]. Environ Toxicol, 2017, 33(2): 581-593. DOI: 10.1002/tox.22261 [22] Yapar K, Çavuşoğlu K, Oruç E, et al. Protective role of Ginkgo biloba against hepatotoxicity and nephrotoxicity in uranium-treated mice[J]. J Med Food, 2010, 13(1): 179-188. DOI: 10.1089/jmf.2009.0028 [23] Petitot F, Lestaevel P, Tourlonias E, et al. Inhalation of uranium nanoparticles: respiratory tract deposition and translocation to secondary target organs in rats[J]. Toxicol Lett, 2013, 217(3): 217-225. DOI: 10.1016/j.toxlet.2012.12.022 [24] Monleau M, de Méo M, Paquet F, et al. Genotoxic and inflammatory effects of depleted uranium particles inhaled by rats[J]. Toxicol Sci, 2006, 89(1): 287-295. DOI: 10.1093/toxsci/kfj010 [25] Periyakaruppan A, Sarkar S, Ravichandran P, et al. Uranium induces apoptosis in lung epithelial cells[J]. Arch Toxicol, 2009, 83(6): 595-600. DOI: 10.1007/s00204-008-0396-5 [26] Rosenberger A, Hung RJ, Christiani DC, et al. Genetic modifiers of radon-induced lung cancer risk: a genome-wide interaction study in former uranium miners[J]. Int Arch Occup Environ Health, 2018, 91(8): 937-950. DOI: 10.1007/s00420-018-1334-3 [27] 陈春玉, 赵凯, 廖志权, 等. 铀矿物的晶体结构与主要研究手段[J]. 能源研究与管理,2021(2):102-109. DOI: 10.16056/j.2096-7705.2021.02.020 Chen CY, Zhao K, Liao ZQ, et al. Crystal structure of uranium minerals and main study approach[J]. Energy Res Manage, 2021(2): 102-109. DOI: 10.16056/j.2096-7705.2021.02.020 [28] 刘春立, 王路化. 铀酰配合物单晶的合成与结构[J]. 化学进展,2011,23(7):1372-1378 Liu CL, Wang LH. Synthesis and crystal structure of uranyl complexes[J]. Prog Chem, 2011, 23(7): 1372-1378 [29] Fattal E, Tsapis N, Phan G. Novel drug delivery systems for actinides (Uranium and Plutonium) decontamination agents[J]. Adv Drug Deliv Rev, 2015, 90: 40-54. DOI: 10.1016/j.addr.2015.06.009 [30] 匙芳廷, 文君, 熊洁, 等. 配体结构对铀配位性能影响的理论研究[J]. 核化学与放射化学,2016,38(4):238-246. DOI: 10.7538/hhx.2016.38.04.0238 Chi FT, Wen J, Xiong J, et al. Density functional theory study on selective complexation of uranyl(VI) with ligands possessing different configuration[J]. J Nucl Radiochem, 2016, 38(4): 238-246. DOI: 10.7538/hhx.2016.38.04.0238 [31] Wang XM, Dai X, Shi C, et al. A 3, 2-hydroxypyridinone-based decorporation agent that removes uranium from bones in vivo[J]. Nat Commun, 2019, 10(1): 2570. DOI: 10.1038/s41467-019-10276-z [32] Ohmachi Y, Imamura T, Ikeda M, et al. Sodium bicarbonate protects uranium-induced acute nephrotoxicity through uranium-decorporation by urinary alkalinization in rats[J]. J Toxicol Pathol, 2015, 28(2): 65-71. DOI: 10.1293/tox.2014-0041 [33] Basinger MA, Forti RL, Burka LT, et al. Phenolic chelating agents as antidotes for acute uranyl acetate intoxication in mice[J]. J Toxicol Environ Health, 1983, 11(2): 237-246. DOI: 10.1080/15287398309530338 [34] Durbin PW, Kullgren B, Ebbe SN, et al. Chelating agents for uranium(VI): 2. Efficacy and toxicity of tetradentate catecholate and hydroxypyridinonate ligands in mice[J]. Health Phys, 2000, 78(5): 511-521. DOI: 10.1097/00004032-200005000-00008 [35] Bao YZ, Wang D, Hu YX, et al. Efficacy of chelator CBMIDA-CaNa2 for the removal of uranium and protection against uranium-induced cell damage in human renal proximal tubular cells[J]. Health Phys, 2013, 105(1): 31-38. DOI: 10.1097/HP.0b013e31828911a0 [36] Bao YZ, Wang D, Li ZM, et al. Efficacy of a novel chelator BPCBG for removing uranium and protecting against uranium-induced renal cell damage in rats and HK-2 cells[J]. Toxicol Appl Pharmacol, 2013, 269(1): 17-24. DOI: 10.1016/j.taap.2013.02.010 [37] 张青春, 时召涛, 金波, 等. 一种双邻苯二酚类衍生物的合成与螯合性能研究[J]. 功能材料,2017,48(10):10130-10136. DOI: 10.3969/j.issn.1001-9731.2017.10.022 Zhang QC, Shi ZT, Jin B, et al. The synthesis and chelating properties of a bis (catecholamine) derivative[J]. J Funct Mater, 2017, 48(10): 10130-10136. DOI: 10.3969/j.issn.1001-9731.2017.10.022 [38] Zhang QC, Jin B, Zheng T, et al. Hexadentate β-dicarbonyl(bis-catecholamine) ligands for efficient uranyl cation decorporation: thermodynamic and antioxidant activity studies[J]. Inorg Chem, 2019, 58(21): 14626-14634. DOI: 10.1021/acs.inorgchem.9b02306 [39] Sturzbecher-Hoehne M, Deblonde GJP, Abergel RJ. Solution thermodynamic evaluation of hydroxypyridinonate chelators 3, 4, 3-LI(1, 2-HOPO) and 5-LIO(Me-3, 2-HOPO) for UO2(VI) and Th(IV) decorporation[J]. Radiochim Acta, 2013, 101(6): 359-366. DOI: 10.1524/ract.2013.2047 [40] Wang XM, Ji GX, Shi C, et al. Structural and thermodynamic stability of uranyl–deferiprone complexes and the removal efficacy of U(VI) at the cellular level[J]. Dalton Trans, 2018, 47(26): 8764-8770. DOI: 10.1039/c8dt01738g [41] Wang XM, Wu SQ, Guan JW, et al. 3-Hydroxy-2-pyrrolidinone as a potential bidentate ligand for in vivo chelation of uranyl with low cytotoxicity and moderate decorporation efficacy: a solution thermodynamics, structural chemistry, and in vivo uranyl removal survey[J]. Inorg Chem, 2019, 58(5): 3349-3354. DOI: 10.1021/acs.inorgchem.8b03442 [42] 郑荣宗, 金波, 彭汝芳, 等. 一种新型双3, 4-羟基吡啶酮类衍生物的合成及铀络合研究[J]. 安全与环境学报,2015,15(3):243-247. DOI: 10.13637/j.issn.1009-6094.2015.03.051 Zheng RZ, Jin B, Peng RF, et al. Synthesis of a novel bis (3-hydroxy-4-pyridinone) ligand as chelating agents for uranyl decorporation[J]. J Saf Environ, 2015, 15(3): 243-247. DOI: 10.13637/j.issn.1009-6094.2015.03.051 [43] 闫镒腾, 金波, 彭汝芳, 等. 一种新型四齿1, 2-HOPO螯合剂的合成、金属配位研究[J]. 安全与环境学报,2017,17(4):1476-1483. DOI: 10.13637/j.issn.1009-6094.2017.04.052 Yan YT, Jin B, Peng RF, et al. Synthesis and metal-complexation of a new tetradentate derivative as a potential therapeutic chelating agent[J]. J Saf Environ, 2017, 17(4): 1476-1483. DOI: 10.13637/j.issn.1009-6094.2017.04.052 [44] 张金生, 田中禾, 李丽华, 等. 壳聚糖及其衍生物在水处理中的应用[J]. 化工新型材料,2019,47(2):51-55 Zhang JS, Tian ZH, Li LH, et al. Application of chitosan and its derivative in water treatment[J]. New Chem Mater, 2019, 47(2): 51-55 [45] 胡丹飞, 毕梦, 袁海浪, 等. 新型促排剂WSC-DTPA纳米粒对内污染铀的促排和防护作用[J]. 辐射研究与辐射工艺学报,2013,31(4):13-18 Hu DF, Bi M, Yuan HL, et al. Decorporation and radiation protection effects of WSC-DTPA nanopaticles on internal uranium exposure[J]. J Radiat Res Radiat Proc, 2013, 31(4): 13-18 [46] Chen SJ, Ko R, Lai EPC, et al. Encapsulated 3, 4, 3-LI(1, 2-HOPO) in chitosan nanoparticles for decorporation via inhalation[J]. Radiat Prot Dosimetry, 2018, 182(1): 107-111. DOI: 10.1093/rpd/ncy139 [47] Shi C, Wang XM, Wan JM, et al. 3, 2-hydroxypyridinone-grafted chitosan oligosaccharide nanoparticles as efficient decorporation agents for simultaneous removal of uranium and radiation-induced reactive oxygen species in vivo[J]. Bioconjugate Chem, 2018, 29(11): 3896-3905. DOI: 10.1021/acs.bioconjchem.8b00711 [48] Bogdanović G, Djordjević A. Carbon nanomaterials: biologically active fullerene derivatives[J]. Srp Arh Celok Lek, 2016, 144(3/4): 222-231. DOI: 10.2298/SARH1604222B [49] Zheng T, Wan XR, Zhang QC, et al. Catechol amide derivatized polyhydroxylated fullerene as potential chelating agents of radionuclides: synthesis, reactive oxygen species scavenging, and cytotoxic studies[J]. J Inorg Biochem, 2020, 203: 110921. DOI: 10.1016/j.jinorgbio.2019.110921 [50] Martinez AB, Mandalunis PM, Bozal CB, et al. Renal function in mice poisoned with oral uranium and treated with ethane-1-hydroxy-1, 1-bisphosphonate (EHBP)[J]. Health Phys, 2003, 85(3): 343-347. DOI: 10.1097/00004032-200309000-00010 [51] Cebrian D, Tapia A, Real A, et al. Inositol hexaphosphate: a potential chelating agent for uranium[J]. Radiat Prot Dosimetry, 2007, 127(1/4): 477-479. DOI: 10.1093/rpd/ncm356 [52] Xu KM, Ge WW, Liang GL, et al. Bisphosphonate-containing supramolecular hydrogels for topical decorporation of uranium-contaminated wounds in mice[J]. Int J Radiat Biol, 2008, 84(5): 353-362. DOI: 10.1080/09553000802029902 [53] Boulet B, Bouvier-Capely C, Cossonnet C. Solvent extraction of U(VI) by calix[6]arenes[J]. Solvent Extr Ion Exc, 2006, 24(3): 319-330. DOI: 10.1080/07366290600646939 [54] Spagnul A, Bouvier-Capely C, Phan G, et al. Ex vivo decrease in uranium diffusion through intact and excoriated pig ear skin by a calixarene nanoemulsion[J]. Eur J Pharm Biopharm, 2011, 79(2): 258-267. DOI: 10.1016/j.ejpb.2011.05.004 [55] Phan G, Semili N, Bouvier-Capely C, et al. Calixarene cleansing formulation for uranium skin contamination[J]. Health Phys, 2013, 105(4): 382-389. DOI: 10.1097/HP.0b013e318298e8d3 [56] Givès S, Phan G, Bouvier-Capely C, et al. Compared in vivo efficiency of nanoemulsions unloaded and loaded with calixarene and soapy water in the treatment of superficial wounds contaminated by uranium[J]. Chem Biol Interact, 2017, 267: 33-39. DOI: 10.1016/j.cbi.2016.11.030 [57] Lahrouch F, Siberchicot B, Leost L, et al. Polyethyleneimine methylenecarboxylate: a macromolecular DTPA analogue to chelate plutonium(IV)[J]. Chem Commun, 2018, 54(83): 11705-11708. DOI: 10.1039/c8cc05206a [58] Lahrouch F, Chamayou AC, Creff G, et al. A combined spectroscopic/molecular dynamic study for investigating a methyl-carboxylated PEI as a potential uranium decorporation agent[J]. Inorg Chem, 2017, 56(3): 1300-1308. DOI: 10.1021/acs.inorgchem.6b02408 [59] Gok C, Gerstmann U, Höllriegl V, et al. Preparation of Ca-alginate biopolymer beads and investigation of their decorporation characteristics for 85Sr, 238U and 234Th by in vitro experiments[J]. Radiat Prot Dosimetry, 2013, 153(1): 47-55. DOI: 10.1093/rpd/ncs088
